Doctor profile · Federal record
Dr. JUSTIN BAKER, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hematology & Oncology Physician · JACKSON, MS
- NPI 1639119589
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 26 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1227 N STATE ST STE 101
JACKSON, MS 392022002
(601) 355-2485
fax (601) 353-1463
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- December 2, 2009
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Mississippi #17499 · Tennessee #MD40878
- Medicaid
- MS #02108317
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639119589. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
232,803
Distinct HCPCS
10
Medicare allowed
$5,178,979
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 56,000 | 45 | $50 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 52,500 | 36 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 35,200 | 27 | $30 | |
J0185 |
Injection, aprepitant, 1 mg | 18,330 | 46 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 16,440 | 46 | $20 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 9,000 | 11 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 7,750 | 15 | $0 | |
J9311 |
Injection, rituximab 10 mg and hyaluronidase | 7,080 | 12 | $37 | |
J9171 |
Injection, docetaxel, 1 mg | 5,190 | 19 | $1 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 3,750 | 88 | $0 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 2,659. This provider delivers 88× the peer median.Open Payments
Industry payments received
All-time total
$557
Transactions
29
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Celgene Corporation | 8 | $148.06 | |
| Janssen Biotech, Inc. | 4 | $62.82 | |
| ABBVIE INC. | 2 | $57.40 | |
| Deciphera Pharmaceuticals Inc. | 3 | $55.25 | |
| Octapharma USA, Inc. | 2 | $36.63 | |
| Eisai Inc. | 1 | $23.46 | |
| Gilead Sciences, Inc. | 1 | $23.06 | |
| BeiGene USA, Inc. | 1 | $21.48 | |
| Inari Medical, Inc. | 1 | $21.35 | |
| Daiichi Sankyo Inc. | 1 | $20.07 | |
| ARRAY BIOPHARMA INC | 1 | $19.88 | |
| Dendreon Pharmaceuticals LLC | 1 | $18.76 | |
| Kite Pharma, Inc. | 1 | $18.07 | |
| PFIZER INC. | 1 | $15.77 | |
| Astellas Pharma US Inc | 1 | $14.71 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,059
Patients
318
Total drug cost
$1,994,143
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 196 | 41 | $2,696 |
| Ondansetron Hcl | Generic | 123 | 76 | $1,849 |
| Prednisone | Generic | 109 | 47 | $638 |
| Imbruvica (Ibrutinib) | Brand | 87 | 0 | $1,192,941 |
| Potassium Chloride | Generic | 77 | 21 | $1,137 |
| Megestrol Acetate | Generic | 57 | 23 | $5,513 |
| Gabapentin | Generic | 55 | 15 | $708 |
| Tamoxifen Citrate | Generic | 55 | 12 | $1,643 |
| Ibandronate Sodium | Generic | 48 | 12 | $878 |
| Imatinib Mesylate | Generic | 48 | 0 | $108,510 |